Cargando…

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this study was undertaken to assess its effects on weig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dawson, Alison J., Sathyapalan, Thozhukat, Vince, Rebecca, Coady, Anne-Marie, Ajjan, Ramzi A., Kilpatrick, Eric S., Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454834/ https://www.ncbi.nlm.nih.gov/pubmed/31001199 http://dx.doi.org/10.3389/fendo.2019.00189

Ejemplares similares

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2019)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
por: Dawson, Alison J., et al.
Publicado: (2017)

Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
por: Kahal, Hassan, et al.
Publicado: (2015)

Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
por: Cho, Li-Wei, et al.
Publicado: (2017)

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
por: Javed, Zeeshan, et al.
Publicado: (2019)

SAT366 Expression of Amyloid-related Proteins Associated With Dementia in Polycystic Ovary Syndrome Compared to a Control Population
por: Butler, Alexandra E, et al.
Publicado: (2023)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D
por: Nandakumar, Manjula, et al.
Publicado: (2023)

The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes – A Cross-over Study
por: Konya, Judit, et al.
Publicado: (2018)

Corrigendum: The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes – A Cross-Over Study
por: Konya, Judit, et al.
Publicado: (2018)

Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
por: Kirk, Richard J., et al.
Publicado: (2019)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
por: Konya, Judit, et al.
Publicado: (2019)

The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020)

Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
por: Ganie, Mohd Ashraf, et al.
Publicado: (2019)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T(3) in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Association of the Polychlorinated Biphenyl Class of Endocrine Disruptors With Polycystic Ovary Syndrome and Thyroid Dysfunction
por: Brennan, Edwina, et al.
Publicado: (2021)

microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_13527kpoum4to3kkoif0ukcrua